What PSA can and can't tell you
PSA is prostate-specific, not cancer-specific. It rises with:
- Prostate cancer
- Benign prostatic enlargement (BPH)
- Prostatitis (inflammation or infection)
- Instrumentation (catheter, cystoscopy, biopsy) and recent ejaculation
- Vigorous cycling shortly before the test
Finasteride and dutasteride roughly halve PSA — your clinician should double the result to interpret it.
Contextualizing PSA
- PSA velocity — how quickly it's changing
- PSA density — PSA divided by prostate volume on imaging
- Free / total PSA ratio
- Secondary markers (4Kscore, PHI, SelectMDx, ExoDx) refine risk before biopsy
Next steps if PSA is elevated
- Rule out infection and confirm on a repeat draw
- Risk-stratify with a secondary marker
- Multiparametric prostate MRI to look for suspicious lesions (PI-RADS scoring)
- Targeted MRI-fusion biopsy only when indicated
PSA is a tool, not a diagnosis. It works best as part of a shared-decision plan with a urologist.